Notice

HOME / Notice / News / EN

EN

NKCL Bio Group signed MOA with Labelle Clinic of Gwang-ju, Korea, regarding NK Cell Treatment FILE HOT

NKCL Bio Group and Labelle Clinic of Gwang-ju, Korea, had signed MOA on April 28th, agreeing upon delivering NK cell treatment. Labelle Clinic has 4 storied building with organized facilities. With director Park Tae-ho, many medical professionals and staff members are working in. Especially, Labelle ...

NKCL | 2020.05.07 | 조회 1642

[Construction of Automated NK Cell cultivation system is progressing smoothly] FILE HOT

Despite the delay due to not enough supply of the materials caused by COVID-19 crisis, the construction of ‘NK Cell GMP Automated Cultivation System’ is running smoothly according to the schedule. We share some of the footages of the construction site. NKCL Bio Group’s Automated Cultivation Center...

NKCL | 2020.05.07 | 조회 2140

NKCL Bio Group Launches ‘NK Rest Brain’ that gives 3-hour deep sleep effect by 30-minute rest program FILE HOT

 NKCL Bio Group Inc. (hereinafter referred to as ‘NKCL Bio Group’) is a Korean Bio Group company that researches and develops NK Immune cell treatment which utilizes NK immune cells. With its competitive technologies including cancer cell target treatment and Automatic NK Cell Cultivation System,...

NKCL | 2020.04.27 | 조회 2257

NKCL Bio Group Inc. expands its infrastructure of domestic hospitals. FILE HOT

NKCL Bio group Inc. (hereinafter referred to as NKCL Bio Group) is a Korean bio company that researches and develops NK immune cell treatment using NK immune cell with its competitive technology. Last year, it had laid the foundation for popularizing NK immune cell treatment by opening the constructi...

NKCL | 2020.04.06 | 조회 1727

“Enforcement ordinance for Advanced Regenerative Bio Law will be prepared in February” FILE HOT

Source: [Medical Observer] http://www.monews.co.kr/news/articleView.html?idxno=207654 “Enforcement ordinance for Advanced Regenerative Bio Law will be prepared in February” “We need to move beyond the bio-similar to the original developing phase”, said Kang Soek-Yeon, director of Biopharmaceutica...

NKCL | 2020.02.19 | 조회 2022
처음 이전  11 12 13 14 15 16 17 18 [ 19 ] 20  다음 마지막